source
- Genentech parts ways with global AI head Richard BonneauGenentech, the Roche biotech unit, announced that its global head of artificial intelligence for drug discovery, computational biologist Richard Bonneau, has left the company effective immediately.…
- Two Massachusetts biotech firms shut down, ending cancer and eye‑disease programsAdecto Pharmaceuticals, a Boston‑based biotech developing a treatment for cancers resistant to standard immunotherapy, announced it has ceased operations as of September 30. CEO Nora Minerva shared…